Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **intestinal mucosal barrier function** refers to the collective ability of the intestinal lining to act as a selective physical and biochemical shield between the internal environment and potentially harmful substances present in the gut lumen. This complex system is composed of several layers: *Physical barriers*: The single layer of epithelial cells joined by tight junctions prevents uncontrolled passage of microorganisms and toxins while allowing nutrient absorption[1][3][4]. Goblet cells secrete mucus that forms a protective gel overlying these cells[1][3]. *Chemical barriers*: Secreted antimicrobial peptides (AMPs), immunoglobulin A (SIgA), and other molecules neutralize pathogens before they reach epithelial surfaces[1][4]. *Immune barriers*: Immune cells within the lamina propria respond rapidly to breaches in physical or chemical defenses[5]. *Microbial barriers*: Commensal microbiota contribute to maintaining homeostasis by outcompeting pathogens and modulating host immunity[2][3]. Disruption or dysfunction in any component can result in increased intestinal permeability ("leaky gut"), which has been implicated in various diseases including inflammatory bowel disease, metabolic disorders, infections, food allergies, celiac disease, diabetes mellitus, non-alcoholic fatty liver disease, septic shock among others[3][4]. **Note:** "Mucosal barrier function" is not a specific molecule or receptor but rather describes an integrated physiological property involving multiple cell types (e.g., epithelial cells), proteins (e.g., claudins/occludin/ZO1), secreted factors (e.g., mucins/AMPs/SIgA), immune components, and microbial interactions. Therefore it does *not* meet criteria for a canonical therapeutic target such as an enzyme or receptor; instead it represents a functional system or process. If you are seeking information on specific molecular targets involved in regulating this function—such as tight junction proteins (claudin family members) or receptors like FXR/TGR5/VDR—please specify further so that structured data can be provided at that level[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosal barrier function.